<![CDATA[Embla Medical — Januar 2025]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/topic/401341/embla-medical-januar-2025RSS for NodeSat, 06 Jun 2026 06:04:58 GMTThu, 09 Jan 2025 04:13:26 GMT60<![CDATA[Reply to Embla Medical — Januar 2025 on Thu, 09 Jan 2025 08:06:09 GMT]]>Participant access code: 274982

]]>https://dev.proinvestor.com/forum/post/8056389https://dev.proinvestor.com/forum/post/8056389Thu, 09 Jan 2025 08:06:09 GMT<![CDATA[Reply to Embla Medical — Januar 2025 on Thu, 09 Jan 2025 08:05:50 GMT]]>To participate in the telephone conference, please use the dial-in details provided below:

DK: +45 78 76 84 90

]]>https://dev.proinvestor.com/forum/post/8056388https://dev.proinvestor.com/forum/post/8056388Thu, 09 Jan 2025 08:05:50 GMT<![CDATA[Reply to Embla Medical — Januar 2025 on Thu, 09 Jan 2025 08:05:28 GMT]]>The call will include a review of the quarterly and full year results and will be held in English.

Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors

]]>https://dev.proinvestor.com/forum/post/8056386https://dev.proinvestor.com/forum/post/8056386Thu, 09 Jan 2025 08:05:28 GMT<![CDATA[Reply to Embla Medical — Januar 2025 on Thu, 09 Jan 2025 08:04:42 GMT]]>Embla Medical hf: Conference call details for Q4/FY 2024

Reykjavik, Iceland/Copenhagen, Denmark, January 9, 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q4/Full Year 2024 Report on 5 February 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 8:00 GMT / 3:00am EST.

The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO.

]]>https://dev.proinvestor.com/forum/post/8056387https://dev.proinvestor.com/forum/post/8056387Thu, 09 Jan 2025 08:04:42 GMT